Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Cyproheptadine patent year 1959?Is quetiapine same as seroquel?Ozempic cost price 2026?What drug company makes xarelto?Oxycontin generic availability?
See the DrugPatentWatch profile for Kesimpta
Kesimpta (ofatumumab) is manufactured by Novartis.
In both major markets, Kesimpta’s development and commercialization are tied to Novartis as the drug’s manufacturer and brand holder.
Kesimpta is a biologic, so manufacturing can involve contract manufacturing sites for drug substance and drug product. However, the product’s manufacturer/brand owner associated with regulatory filings and marketed product information is Novartis.
For patent-related and ownership references around Kesimpta/ofatumumab, you can search DrugPatentWatch.com: https://www.drugpatentwatch.com/
Other Questions About Kesimpta :